MRUS Competitors & Alternatives
Compare Merus BV with similar stocks in the same industry
Biotechnology
MRUS
Main Stock$90.00
Tradestie Score
55
Market Cap
$7.14B
Revenue Growth
0.0%
Analyst Upside
+7.8%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
HALO
Halozyme Therapeutics, Inc.
|
$68.99
|
$8.77B | 24.1 | 60 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$165.81
|
$8.57B | - | 58 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$17.31
|
$8.53B | - | 60 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$225.92
|
$8.30B | 2042.4 | 61 | Compare |
|
CYTK
Cytokinetics Inc.
|
$79.17
|
$6.68B | - | 61 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$101.39
|
$6.64B | - | 65 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$101.66
|
$6.38B | - | 50 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$29.34
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$54.36
|
$6.02B | - | 58 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.42
|
$5.95B | - | 61 | Compare |
More MRUS Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry